DR info

Clinical trials : 5 / Drugs : 7 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 10

Myelomeningocele and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
118	Myelomeningocele
6	Parkinson disease
169	Menkes disease
170	Occipital horn syndrome
22	Moyamoya disease
11	Myasthenia gravis
206	Fragile X syndrome
113	Muscular dystrophy
17	Multiple system atrophy
5	Progressive supranuclear palsy
70	Spinal stenosis
96	Crohn disease
2	Amyotrophic lateral sclerosis
46	Malignant rheumatoid arthritis
280	Huge arteriovenous malformation with cervicofacial or limb lesion
288	Autoimmune acquired coagulation factor deficiency
8	Huntington disease
13	Multiple sclerosis/Neuromyelitis optica
323	Aromatic L-amino acid decarboxylase deficiency
57	Idiopathic dilated cardiomyopathy
215	Tetralogy of Fallot
210	Single Ventricle
127	Frontotemporal lobar degeneration
226	Interstitial cystitis with Hunners ulcer
85	Idiopathic interstitial pneumonia
86	Pulmonary arterial hypertension
212	Tricuspid atresia
4	Primary lateral sclerosis
254	Porphyria
67	Polycystic kidney disease
78	Hypopituitarism
21	Mitochondrial disease
58	Hypertrophic cardiomyopathy
90	Retinitis pigmentosa
107	Juvenile idiopathic arthritis
28	Systemic amyloidosis
34	Neurofibromatosis
65	Primary immunodeficiency
111	Congenital myopathy